US20060195158A1 - Nerve Stimulator and Method - Google Patents

Nerve Stimulator and Method Download PDF

Info

Publication number
US20060195158A1
US20060195158A1 US11/381,741 US38174106A US2006195158A1 US 20060195158 A1 US20060195158 A1 US 20060195158A1 US 38174106 A US38174106 A US 38174106A US 2006195158 A1 US2006195158 A1 US 2006195158A1
Authority
US
United States
Prior art keywords
electrical
electrode
tissue
needle electrode
pulse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/381,741
Inventor
Philip Cory
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/381,741 priority Critical patent/US20060195158A1/en
Publication of US20060195158A1 publication Critical patent/US20060195158A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/05Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/053Measuring electrical impedance or conductance of a portion of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/40Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4029Detecting, measuring or recording for evaluating the nervous system for evaluating the peripheral nervous systems
    • A61B5/4041Evaluating nerves condition
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36017External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin

Definitions

  • This invention relates to the stimulation of nerves with invasive electrodes for targeted therapeutic interventions.
  • Nerve stimulators commercially available for targeted nerve therapies are exemplified by the NeuroTrace III (HDC Corp., Milpitas, Calif.), the Stimuplex (B.Braun America, Bethlehem, Pa.) and the Digistim III (NeuroTechnologies, Inc, India), among others.
  • These devices are constant current, monophasic, pulsed square waveform generators having pulse widths no longer than 200 microseconds in duration.
  • These devices are connected to insulated hypodermic needles which are inserted through the skin and advanced toward the presumed position of a target nerve. Accurate localization of the needle tip is presumed when either a sensory paresthesia or a motor paresthesia is provoked by current outputs less than 0.5 mA. This work is derived from historical strength-duration curves. However, there are several problems with these devices.
  • Tissue can be represented in equivalent electrical circuits as an RC circuit.
  • the associated voltage shows a charging curve as depicted from Nervonix experimental data in FIG. 2 .
  • a constant current pulse was directed across tissue via a 22G insulated needle or a 24G insulated needle. These data demonstrate that the applied voltage only reaches its maximum toward the end of the 2.5 ms pulse. If the pulse had ended at 0.2 ms, as the commercially available nerve stimulators provide, the voltage would be well short of its maximum value.
  • this invention uses a percutaneous needle electrode for the performance of therapeutic interventions targeting nerves.
  • the needle is insulated from the patient except at the tip of the needle, which is to be inserted to within a millimeter or so of a nerve or nerve plexus.
  • a conventional gel-type ground (return) electrode is also used superficially, and an electrical waveform is applied between the two electrodes.
  • This invention presents a device (and the method it implements) to improve the design of the nerve stimulators found in prior art.
  • the improvement comprises offering the option for either constant current or constant voltage, offering a wider choice of waveform parameters controlling a pulse generator, supplying a second (background) waveform, measuring the current and voltage applied to the tissue, computing further electrical characteristics from the measurements, adjusting circuit components to insure that a particular waveform is applied to the tissue between the electrodes, and displaying the measured and computed electrical characteristics of the tissue.
  • this invention comprises a pulse conditioning circuit and method to ensure that the desired waveform and amplitude actually develops across the electrodes. It also comprises two waveform generators.
  • This invention provides several objectives and advantages. First, it provides a means of developing a predictable voltage gradient across the neuronal cell membrane. Second, the invention provides a means of maintaining the voltage output despite changes in load. Third, the invention provides a means for delivering an adequate pulse duration for neuronal cell depolarization. Fourth, the invention provides a means for the determination of tissue electrical parameters. Fifth, the invention provides a means for adjusting output characteristics based on measured tissue electrical parameters. The principal advantage of a system satisfying these objects is improved localization of nerves or nerve plexuses for regional anesthesia, pain management, and other medical purposes.
  • Attaining those objectives will support more accurate positioning of a needle tip in proximity to nerves or nerve plexuses for the following applications: local anesthetic injection for regional anesthesia purposes; local anesthetic injection for pain management purposes; catheter placement for injection purposes; and injection of other agents acting on nerve for therapeutic purposes (i.e. neurotoxins, nerve growth factor, . . . )
  • FIG. 1 graphs empirical impedances for a 24G Stimuplex insulated needle at various needle tip depths using 40 microampere constant current output. Nerve position was determined to be 7.5 mm below the skin surface.
  • FIG. 2 graphs empirical voltages of a 48 microampere, 2.5 millisecond, square wave output across subcutaneous, 22G and 24G Stimulplex needles with a return (ground) electrode at a distance of about 20 centimeters.
  • FIG. 3 is a schematic diagram of the electronic circuitry and of the data and control paths of a means to measure and compute electrical characteristics and to adjust the circuitry characteristics. This measurement, computation, and adjustment could presumably be automated by computer hardware and software.
  • FIG. 4 depicts a representative graph of the amplitude of the voltage applied across the electrodes (or, alternatively, current through the tissue).
  • the solid lines represent electronic circuitry.
  • the dotted box 50 represents the nerve-containing tissue and encloses an equivalent resistance and capacitance between the needle electrode 21 and the return electrode 22 .
  • the tissue resistance and capacitance vary, as the needle is advanced through the tissue-presumably toward a nerve.
  • the circuitry comprises two waveform generators 31 and 32 , a pulse conditioning circuit 10 with a variable resistor 11 and a variable capacitor 12 , a switch 35 which connects one of the two generators at a time into the circuitry, a percutaneous needle electrode 21 , a ground electrode 22 , and sensors 41 and 42 to measure electrical characteristics such as instantaneous voltage and current between the electrodes in real time.
  • Resistor-capacitor (RC) circuit 50 represents the effective electrical characteristics of the tissue conducting the waveform developed between the electrodes 21 and 22 .
  • the dashed lines represent data acquisition, calculation, and control of variable elements of the circuitry. Although the dashed lines could represent manual operation by a human user, the intent of this invention is to automate the broken-line portion of FIG. 3 with the hardware and software of a digital computer.
  • the digital computer might include a conventional laptop computer with hardware input/output interfaces, or it may be a completely custom system.
  • the acquisition and control form a controlled feed-back system, which can measure the voltage 41 across the electrodes 21 and 22 and the current 42 through them. In response, it can control the two waveform generators 31 and 32 , the capacitance 12 and resistance 11 values of the pulse conditioning circuit 10 , and the selection and duration of the applied waveforms by means of switch 35 .
  • the needle electrode 21 may be any commercially available needle for use with traditional nerve stimulators. They insulate the electrode from the tissue of the patient except at the tip of the needle 21 .
  • the return (ground) electrode 22 may also be a conventional gel-type electrode, preferably located approximately 20 centimeters away from the anatomical location of the needle.
  • Pulse conditioning circuit 10 in series with the electrical path through the tissue 50 .
  • Waveform generator 31 applies a waveform across this combination circuit.
  • Pulse conditioning circuit 10 is shown simply as a variable resistor 11 and variable capacitor 12 in parallel, although a more complex circuit employing active semiconductor components would likely be used.
  • Pulse conditioning circuit 10 affects the waveform and is intended to introduce circuit characteristics so that the waveform across the electrodes approximates a desired waveform-such as a square pulse, unlike FIG. 2 .
  • the components of the pulse conditioning circuit 10 are adjustable, so that as the needle electrode 21 penetrates tissue 50 and the effective electrical characteristics of the tissue therefore change, the characteristics of pulse conditioning circuit 10 can be adjusted to maintain the desired waveform across the electrodes 21 and 22 .
  • a waveform includes both voltage and current components, which can be out of phase in a circuit with reactive impedance.
  • the voltage and current may not be linearly related as the tissue impedance changes with needle insertion and because of non linear impedance characteristics of neurons. Therefore, in a digital implementation, the waveform may be frequently sampled and represented by a sufficiently complete, discrete sequence of voltage and current values. From them the impedance of the circuit can be computed. Alternatively, analog circuits may simply measure the minimum and maximum (or perhaps the average or root-mean-square) values of voltage or current, and from that the impedance can be derived using well-known electronics formulas.
  • the impedance of pulse conditioning circuit 10 at a particular setting may be represented as a complex number representing the combined effects of resistance and reactance. Similarly the effective immediate impedance of the tissue between the electrodes is also a complex value, which changes as the needle electrode is advanced.
  • the parametric characteristics of pulse conditioning circuit 10 and of the generators 31 and 32 may be adjusted manually by the operator of the device.
  • the dashed lines of FIG. 3 represent the device's operation by a human being.
  • controller 60 which is a digital computer.
  • the computer would input user choices 61 and a sequence of real-time voltage and current measurements 41 and 42 , calculate other circuit characteristics from those measurements, derive the current and voltage waveforms, and adjust pulse conditioning circuit 10 appropriately to maintain the desired complex waveform.
  • controller 60 would adjust the shape and amplitude of the waveforms generated by generators 31 and 32 as well as their duration and selection by means of switch 35 . At least some of that information 62 would be displayed for use by the medical practitioner inserting the needle electrode 21 .
  • the variable resistor 11 , the variable capacitor 12 , and the switch 35 likely would comprise solid state electronically varied components.
  • pulse waveform generator 31 is a constant current source
  • pulse conditioning circuit 10 can be adjusted to produce a waveform across the electrodes which approximates a square voltage waveform. Also, pulse generator 31 can be adjusted to produce the desired amplitude. The rationale for this is to maintain a sufficient and fixed voltage differential between the electrodes during the stimulation pulse.
  • the invention would provide an adjustable voltage range for pulse generator 31 which preferably would include the voltages from 0 up to 24 volts.
  • the current range would preferably include currents from 0 to at least 5 milliamperes.
  • the settings for pulse generator 31 can include a repetition frequency range of 1 to 5 Hertz and a pulse duration of 0.1 to 3 milliseconds.
  • the device of this invention further comprises a second (background) waveform generator 32 . It produces a periodic waveform, such as a sinusoidal wave, which is applied directly between the electrodes during the interval between the pulses generated by pulse generator 31 .
  • a periodic waveform such as a sinusoidal wave
  • switch 35 could be manually controlled to select which of generators 31 or 32 is actively connected
  • the invention preferably employs a solid state switch electronically activated by computer-based control function 60 .
  • the background waveform is applied to the electrodes when and only when the pulse generator is generating zero or minimum amplitude. This is depicted in FIG. 4 , which shows waveform 91 generated by the pulse generator 31 and waveform 92 generated by the background (or secondary) generator.
  • FIG. 4 shows waveform 91 generated by the pulse generator 31 and waveform 92 generated by the background (or secondary) generator.
  • FIG. 4 shows waveform 91 generated by the pulse generator 31 and waveform 92 generated by the background (or secondary) generator.
  • FIG. 4 shows waveform
  • the amplitudes and frequencies of both waveform generators 31 and 32 can be adjusted by the operator or can be set by control function 60 . Additionally, the user can opt whether each generator sources a current waveform or a voltage waveform. (Herein define the selected amplitude as the peak-to-peak amplitude, although it could be the peak amplitude or root-mean-square amplitude instead.) Furthermore, the pulse width (duration) of the output pulse of generator 31 can be set. A more sophisticated variation of this embodiment would also allow the user (or control function 60 ) to control the shapes of each of the waveforms output by generators 31 and 32 .
  • the secondary (background) generator 32 would preferably use a constant current output with a selectable frequency in a preferred range of 500 to 10000 Hertz. Current would be limited to 100 microamperes.
  • the purpose of the second (background) waveform generator is to allow a more passive detection of the proximity of a nerve or nerve plexus without explicitly stimulating the nerve above activation threshold.
  • FIG. 3 further depicts a voltmeter 41 and an ammeter 42 at preferred locations.
  • sensors could be deployed in other parts of the circuitry. These could be analog or digital devices. They could each provide human-oriented readouts. More preferably the sensors would be analog-to-digital converters connected as digital inputs to a computerized controller 60 .
  • a current-measuring sensor would undoubtedly be a voltage sensor wired across (in parallel with) a low-resistance precision resistor.
  • waveform generators 31 and 32 Internal details for the waveform generators 31 and 32 are ignored here, because circuits for various kinds of current-controlled or voltage-controlled waveform generators are well known to those with reasonable skill in electronics. Similarly, circuits for electronic switch 35 and for measuring voltage 41 and current 42 are well known.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Electrotherapy Devices (AREA)

Abstract

This invention presents a device, and the method it implements, which is an improvement in the design of nerve stimulators. Like conventional stimulators, it uses a percutaneous, insulated needle for the performance of therapeutic interventions targeting nerves. The improvement comprises offering an option for either constant current or constant voltage, offering a choice of waveform parameters, controlling a pulse generator, supplying a second background waveform, measuring the current and voltage applied to the tissue, computing further electrical characteristics, dynamically adjusting circuit components to ensure a desirable waveform applied to the tissue, and displaying measured and computed electrical characteristics of the tissue. The object is improved positioning of a needle tip near a nerve or nerve plexus for regional anesthesia, pain management, and other medical purposes.

Description

    RELATED APPLICATIONS
  • This application is a continuation of and claims the benefit of priority to U.S. patent application Ser. No. 10/853,590, filed on May 25, 2004.
  • FIELD OF INVENTION
  • This invention relates to the stimulation of nerves with invasive electrodes for targeted therapeutic interventions.
  • BACKGROUND
  • Nerve stimulators commercially available for targeted nerve therapies are exemplified by the NeuroTrace III (HDC Corp., Milpitas, Calif.), the Stimuplex (B.Braun America, Bethlehem, Pa.) and the Digistim III (NeuroTechnologies, Inc, Chennai, India), among others. These devices are constant current, monophasic, pulsed square waveform generators having pulse widths no longer than 200 microseconds in duration. These devices are connected to insulated hypodermic needles which are inserted through the skin and advanced toward the presumed position of a target nerve. Accurate localization of the needle tip is presumed when either a sensory paresthesia or a motor paresthesia is provoked by current outputs less than 0.5 mA. This work is derived from historical strength-duration curves. However, there are several problems with these devices.
  • The following references will be used to discuss relevant prior art and inadequacies.
  • 1. Cooper M S. Membrane Potential Perturbations Induced in Tissue Cells by Pulsed Electric Fields. Bioelectromagnetics 1995; 16:255-62.
  • 2. Vloka J D and Hadzic A. The Intensity of the Current at Which Sciatic Nerve Stimulation Is Achieved Is More Important Factor in Determining the Quality of Nerve Block That the Type of Motor Response Obtained. Anesthesiology 1998; 88(5):1408-10.
  • 3. Barthram C N. Nerve Stimulators for Nerve Location—Are They All the Same? Anaesthesia 1997; 52:761-4.
  • 4. Pither, C. E., Raj, P. P., and Ford, D. J. The Use of Peripheral Nerve Stimulators for Regional Anesthesia: A Review of Experimental Characteristics, Technique and Clinical Applications. Reg Anesth 1985; 10(2):49-58.
  • 5. Andres, J D. and Sala-Blanch, X. Peripheral Nerve Stimulation in the Practice of Brachial Plexus Anesthesia: A Review. Reg Anesth Pain Med 2001; 26(5):478-83.
  • 6. Hadzic A; Vloka J, Hadzic N, Thys D M, Santos A C. Nerve stimulators used for peripheral nerve blocks vary in their electrical characteristics. Anesthesiology 2003; 98(4):969-74.
  • 7. Urmey, W. F. Interscalene Block: The Truth About Twitches. Reg Anesth Pain Med 2000; 25(4):340-2.
  • 8. Urmey, W. F.; Stanton, J.; O'Brien, S.; Tagariello, V.; Wickiewicz, T. L. Inability to Consistently Elecit a Motor Response Following Sensory Paresthesia During Interscalene Block Administration. Reg Anesth 23, 7. 1998.
  • 9. Choyce A; Chan V W; Knight W J; Peng P; McCartney C J. What is the relationship between paresthesia and nerve stimulation for axillary brachial plexus block? Reg Anesth Pain Med 26[2], 100-104. 2001.
  • 10. Hille B. Ionic Basis of Resting and Action Potentials. Brookhart, J. M., Mountcastle, V. B., and Kandel, E. R. The Nervous System Baltimore, Md.: Waverly Press, Inc; 1977. pp. 99-136.
  • 11. Hodgkin A L and Huxley A F. A Quantitative Description of Membrane Current and Its Application to Conduction and Excitation in Nerve. J Physiol 1952; 117:500-44.
  • 12. Cole K S, Membranes, ions, and impulses. Berkeley and Los Angeles: University of California Press; 1972. (Biophysics Series; 1).
  • 13. Rall W. Core Conductor Theory and Cable Properties of Neurons. Brookhart, J. M., Mountcastle, V. B., and Kandel, E. R. Handbook of Physiology, section 1, The Nervous System Baltimore, Md.: Baltimore, Md.; 1977. pp. 39-97.
  • Cooper (reference 1 above) developed a mathematical description of the necessary parameters of externally applied, pulsed electric fields for effective nerve stimulation. There are two important concepts that derive from his work. First, an adequate voltage gradient must be generated across the neuronal cell membrane for effective depolarization of the nerve cell to occur. Second, an externally applied electric field must have a pulse duration that is at least 0.5 times the neuronal cell membrane time constant to cause reproducible depolarization.
  • Anesthesia literature is replete with papers concerning nerve stimulation. In all of these works, the applied current is seen as an important parameter (references 2-9). However, examination of the Hodgkin-Huxley equations reveals that current does not play a role in the opening of membrane sodium or potassium channels. Opening of these channels is required for nerve depolarization to occur (see references 10-12). The role that applied current plays in nerve depolarization is related to the associated voltage gradient required to drive the current through the load represented by the tissue impedance. At a first level approximation, the current to voltage relationship follows Ohm's Law, or E=I·R, where E is voltage, I is current, and R is resistance. Clearly, at constant current, the voltage will vary directly with the load. During placement of a needle for nerve stimulation, the load varies with distance from the nerve, as shown by Nervonix experimental data in FIG. 1. Since the impedance decreases as the needle tip approaches the nerve, the applied voltage will also decrease, making the development of an adequate voltage gradient for depolarization unpredictable.
  • An additional factor in achieving adequate voltage with constant current output is the resistance-capacitance (RC) nature of tissue. Tissue can be represented in equivalent electrical circuits as an RC circuit. When any RC circuit is exposed to a constant current pulse, the associated voltage shows a charging curve as depicted from Nervonix experimental data in FIG. 2. A constant current pulse was directed across tissue via a 22G insulated needle or a 24G insulated needle. These data demonstrate that the applied voltage only reaches its maximum toward the end of the 2.5 ms pulse. If the pulse had ended at 0.2 ms, as the commercially available nerve stimulators provide, the voltage would be well short of its maximum value.
  • Finally, there are a many references regarding the time constant of motoneurons. Rall (reference 13) summarizes these studies, which show that motoneuron membrane time constants range from 3 ms to 7 ms. Based on Cooper's work, if a pulse is to be of adequate duration to reproducibly cause neuronal cell depolarization, it must be greater than 1.5 ms. The commercially available nerve stimulators operate well below this level.
  • SUMMARY OF THE INVENTION
  • As with a conventional nerve stimulator, this invention uses a percutaneous needle electrode for the performance of therapeutic interventions targeting nerves. The needle is insulated from the patient except at the tip of the needle, which is to be inserted to within a millimeter or so of a nerve or nerve plexus. A conventional gel-type ground (return) electrode is also used superficially, and an electrical waveform is applied between the two electrodes.
  • This invention presents a device (and the method it implements) to improve the design of the nerve stimulators found in prior art. The improvement comprises offering the option for either constant current or constant voltage, offering a wider choice of waveform parameters controlling a pulse generator, supplying a second (background) waveform, measuring the current and voltage applied to the tissue, computing further electrical characteristics from the measurements, adjusting circuit components to insure that a particular waveform is applied to the tissue between the electrodes, and displaying the measured and computed electrical characteristics of the tissue. In particular, this invention comprises a pulse conditioning circuit and method to ensure that the desired waveform and amplitude actually develops across the electrodes. It also comprises two waveform generators.
  • This invention provides several objectives and advantages. First, it provides a means of developing a predictable voltage gradient across the neuronal cell membrane. Second, the invention provides a means of maintaining the voltage output despite changes in load. Third, the invention provides a means for delivering an adequate pulse duration for neuronal cell depolarization. Fourth, the invention provides a means for the determination of tissue electrical parameters. Fifth, the invention provides a means for adjusting output characteristics based on measured tissue electrical parameters. The principal advantage of a system satisfying these objects is improved localization of nerves or nerve plexuses for regional anesthesia, pain management, and other medical purposes.
  • Attaining those objectives will support more accurate positioning of a needle tip in proximity to nerves or nerve plexuses for the following applications: local anesthetic injection for regional anesthesia purposes; local anesthetic injection for pain management purposes; catheter placement for injection purposes; and injection of other agents acting on nerve for therapeutic purposes (i.e. neurotoxins, nerve growth factor, . . . )
  • DESCRIPTION OF THE DRAWINGS
  • The accompanying drawings, which are incorporated herein and form a part of the specification, illustrate a preferred embodiment of the present invention and, together with the description, serve to explain the principle of the invention.
  • FIG. 1 graphs empirical impedances for a 24G Stimuplex insulated needle at various needle tip depths using 40 microampere constant current output. Nerve position was determined to be 7.5 mm below the skin surface.
  • FIG. 2 graphs empirical voltages of a 48 microampere, 2.5 millisecond, square wave output across subcutaneous, 22G and 24G Stimulplex needles with a return (ground) electrode at a distance of about 20 centimeters.
  • FIG. 3 is a schematic diagram of the electronic circuitry and of the data and control paths of a means to measure and compute electrical characteristics and to adjust the circuitry characteristics. This measurement, computation, and adjustment could presumably be automated by computer hardware and software.
  • FIG. 4 depicts a representative graph of the amplitude of the voltage applied across the electrodes (or, alternatively, current through the tissue).
  • DETAILED DESCRIPTION OF A PREFERRED EMBODIMENT
  • A description of the preferred embodiment and some variations will make reference to the schematic diagram in FIG. 3. The solid lines represent electronic circuitry. The dotted box 50 represents the nerve-containing tissue and encloses an equivalent resistance and capacitance between the needle electrode 21 and the return electrode 22. The tissue resistance and capacitance vary, as the needle is advanced through the tissue-presumably toward a nerve.
  • The circuitry comprises two waveform generators 31 and 32, a pulse conditioning circuit 10 with a variable resistor 11 and a variable capacitor 12, a switch 35 which connects one of the two generators at a time into the circuitry, a percutaneous needle electrode 21, a ground electrode 22, and sensors 41 and 42 to measure electrical characteristics such as instantaneous voltage and current between the electrodes in real time. Resistor-capacitor (RC) circuit 50 represents the effective electrical characteristics of the tissue conducting the waveform developed between the electrodes 21 and 22.
  • The dashed lines represent data acquisition, calculation, and control of variable elements of the circuitry. Although the dashed lines could represent manual operation by a human user, the intent of this invention is to automate the broken-line portion of FIG. 3 with the hardware and software of a digital computer. The digital computer might include a conventional laptop computer with hardware input/output interfaces, or it may be a completely custom system. In any case the acquisition and control form a controlled feed-back system, which can measure the voltage 41 across the electrodes 21 and 22 and the current 42 through them. In response, it can control the two waveform generators 31 and 32, the capacitance 12 and resistance 11 values of the pulse conditioning circuit 10, and the selection and duration of the applied waveforms by means of switch 35.
  • The needle electrode 21 may be any commercially available needle for use with traditional nerve stimulators. They insulate the electrode from the tissue of the patient except at the tip of the needle 21. The return (ground) electrode 22 may also be a conventional gel-type electrode, preferably located approximately 20 centimeters away from the anatomical location of the needle.
  • An important aspect of the present invention is the pulse conditioning circuit 10 in series with the electrical path through the tissue 50. Waveform generator 31 applies a waveform across this combination circuit. Pulse conditioning circuit 10 is shown simply as a variable resistor 11 and variable capacitor 12 in parallel, although a more complex circuit employing active semiconductor components would likely be used. Pulse conditioning circuit 10 affects the waveform and is intended to introduce circuit characteristics so that the waveform across the electrodes approximates a desired waveform-such as a square pulse, unlike FIG. 2. The components of the pulse conditioning circuit 10 are adjustable, so that as the needle electrode 21 penetrates tissue 50 and the effective electrical characteristics of the tissue therefore change, the characteristics of pulse conditioning circuit 10 can be adjusted to maintain the desired waveform across the electrodes 21 and 22.
  • Note that a waveform includes both voltage and current components, which can be out of phase in a circuit with reactive impedance. Furthermore, the voltage and current may not be linearly related as the tissue impedance changes with needle insertion and because of non linear impedance characteristics of neurons. Therefore, in a digital implementation, the waveform may be frequently sampled and represented by a sufficiently complete, discrete sequence of voltage and current values. From them the impedance of the circuit can be computed. Alternatively, analog circuits may simply measure the minimum and maximum (or perhaps the average or root-mean-square) values of voltage or current, and from that the impedance can be derived using well-known electronics formulas. The impedance of pulse conditioning circuit 10 at a particular setting may be represented as a complex number representing the combined effects of resistance and reactance. Similarly the effective immediate impedance of the tissue between the electrodes is also a complex value, which changes as the needle electrode is advanced.
  • The parametric characteristics of pulse conditioning circuit 10 and of the generators 31 and 32 may be adjusted manually by the operator of the device. In that case the dashed lines of FIG. 3 represent the device's operation by a human being. However, it is preferred that such operation be automated by a controller 60, which is a digital computer. The computer would input user choices 61 and a sequence of real-time voltage and current measurements 41 and 42, calculate other circuit characteristics from those measurements, derive the current and voltage waveforms, and adjust pulse conditioning circuit 10 appropriately to maintain the desired complex waveform. Furthermore, controller 60 would adjust the shape and amplitude of the waveforms generated by generators 31 and 32 as well as their duration and selection by means of switch 35. At least some of that information 62 would be displayed for use by the medical practitioner inserting the needle electrode 21. In this case the variable resistor 11, the variable capacitor 12, and the switch 35 likely would comprise solid state electronically varied components.
  • Therefore, if the pulse waveform generator 31 is a constant current source, pulse conditioning circuit 10 can be adjusted to produce a waveform across the electrodes which approximates a square voltage waveform. Also, pulse generator 31 can be adjusted to produce the desired amplitude. The rationale for this is to maintain a sufficient and fixed voltage differential between the electrodes during the stimulation pulse.
  • The invention would provide an adjustable voltage range for pulse generator 31 which preferably would include the voltages from 0 up to 24 volts. The current range would preferably include currents from 0 to at least 5 milliamperes. The settings for pulse generator 31 can include a repetition frequency range of 1 to 5 Hertz and a pulse duration of 0.1 to 3 milliseconds.
  • The device of this invention further comprises a second (background) waveform generator 32. It produces a periodic waveform, such as a sinusoidal wave, which is applied directly between the electrodes during the interval between the pulses generated by pulse generator 31. Although switch 35 could be manually controlled to select which of generators 31 or 32 is actively connected, the invention preferably employs a solid state switch electronically activated by computer-based control function 60. For this preferred embodiment, it is assumed that the background waveform is applied to the electrodes when and only when the pulse generator is generating zero or minimum amplitude. This is depicted in FIG. 4, which shows waveform 91 generated by the pulse generator 31 and waveform 92 generated by the background (or secondary) generator. Of course, other ways of combining the waveforms are possible, including adding them or providing a period when neither is applied to the electrodes.
  • As suggested in FIG. 3, the amplitudes and frequencies of both waveform generators 31 and 32 can be adjusted by the operator or can be set by control function 60. Additionally, the user can opt whether each generator sources a current waveform or a voltage waveform. (Herein define the selected amplitude as the peak-to-peak amplitude, although it could be the peak amplitude or root-mean-square amplitude instead.) Furthermore, the pulse width (duration) of the output pulse of generator 31 can be set. A more sophisticated variation of this embodiment would also allow the user (or control function 60) to control the shapes of each of the waveforms output by generators 31 and 32.
  • The secondary (background) generator 32 would preferably use a constant current output with a selectable frequency in a preferred range of 500 to 10000 Hertz. Current would be limited to 100 microamperes. The purpose of the second (background) waveform generator is to allow a more passive detection of the proximity of a nerve or nerve plexus without explicitly stimulating the nerve above activation threshold.
  • FIG. 3 further depicts a voltmeter 41 and an ammeter 42 at preferred locations. Of course, other such sensors could be deployed in other parts of the circuitry. These could be analog or digital devices. They could each provide human-oriented readouts. More preferably the sensors would be analog-to-digital converters connected as digital inputs to a computerized controller 60. A current-measuring sensor would undoubtedly be a voltage sensor wired across (in parallel with) a low-resistance precision resistor.
  • Internal details for the waveform generators 31 and 32 are ignored here, because circuits for various kinds of current-controlled or voltage-controlled waveform generators are well known to those with reasonable skill in electronics. Similarly, circuits for electronic switch 35 and for measuring voltage 41 and current 42 are well known.
  • While this invention is described above with reference to a preferred embodiment, anyone skilled in the art can readily visualize alternative embodiments of this invention. Therefore, the scope and content of this invention are not limited by the foregoing description. Rather, the scope and content are delineated by the following claims.

Claims (20)

1. A system for nerve stimulation via an insulated needle for the performance of therapeutic interventions targeting nerves within tissue, comprising:
a needle electrode with an exterior surface which includes an electrical insulator except near a tip of the needle electrode, wherein the electrical insulator is configured so as to electrically insulate the needle electrode from tissue except at the tip of the needle electrode when the needle electrode is inserted in tissue;
a return electrode;
an electrical sensor coupled to the needle electrode and return electrode, the electrical sensor configured to sense electrical properties of a circuit formed between the needle electrode and return electrode when the needle electrode and return electrode are applied to tissue; and
a processor coupled to the electrical sensor, the processor configured to calculate waveform characteristics from the sensed electrical properties measurements and, based on the calculated waveform characteristics, adjust characteristics of electrical signals applied to the needle electrode and return electrode so as to produce a desired waveform in the circuit formed between the needle electrode and return electrode.
2. The system according to claim 1, further comprising a pulse conditioning circuit electrically coupled to the needle electrode and return electrode, the pulse conditioning circuit configured to adjust electrical characteristics of the circuit formed between the needle electrode and return electrode in response to control signals received from the processor.
3. The system according to claim 2, wherein the pulse conditioning circuit comprises:
an adjustable resistor; and
an adjustable capacitor electrically coupled in parallel with the adjustable resistor.
4. The system according to claim 2, further comprising a first pulse generator coupled to the pulse conditioning circuit and to the circuit formed between the needle electrode and return electrode.
5. The system according to claim 1, further comprising:
a first pulse generator;
a second pulse generator; and
a switch electrically coupled to the first and second pulse generators, the needle electrode and the return electrode, wherein the switch is configured to complete a circuit formed between the needle electrode and return electrode through either the first pulse generator or the second pulse generator in response to a control signal received from the processor.
6. The system according to claim 5, further comprising a pulse conditioning circuit electrically coupled to the first pulse generator and configured to adjust electrical characteristics of the circuit formed between the needle electrode and return electrode in response to control signals received from the processor.
7. The system according to claim 6, wherein the first pulse generator is configured to receive control signals from the processor and, in response to the control signals, produce pulses with particular waveform characteristics.
8. The system according to claim 7, wherein the second pulse generator is configured to receive control signals from the processor and, in response to the control signals, produce pulses with particular waveform characteristics.
9. The system according to claim 8, wherein the second pulse generator is configured to produce periodic pulses of with particular waveform characteristics.
10. An apparatus for stimulating nerves within tissue by applying an electrical potential to a needle electrode and a return electrode when the needle electrode and return electrode are applied to tissue, the apparatus comprising:
an electrical sensor configured to sense an electrical characteristic of a circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue;
a pulse generator configured to apply an electrical pulse to the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue; and
a processor electronically coupled to the electrical sensor and configured to receive the sensed electrical characteristic and, based upon the sensed electrical characteristics, control an electrical parameter so as to produce a desired pulse waveform in the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue.
11. The apparatus of claim 10, further comprising a pulse conditioning circuit electrically coupled to the pulse generator and electronically coupled to the processor, wherein:
the processor is configured to send control signals to the pulse conditioning circuit to control the electrical parameter; and
the pulse conditioning circuit is configured to adjust the electrical parameter in response to the control signals received from the processor.
12. The apparatus of claim 11, wherein:
the processor is further configured to send control signals to the pulse generator; and
the pulse generator is configured to generate electrical pulses of particular characteristics in response to the control signals received from the pulse generator.
13. The apparatus of claim 10, further comprising:
a waveform generator configured to apply an electrical potential having a waveform of particular characteristics to the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue; and
a switch configured to electrically connect the waveform generator or the pulse generator to the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue.
14. The apparatus of claim 13, wherein:
the switch is further configured to receive control signals from the processor and, in response to the control signals, connect the waveform generator or the pulse generator to the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue; and
the processor configured to send control signals to the switch so as to control the application and duration of electrical pulses and waveform electrical potential applied to the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue.
15. The apparatus of claim 10, wherein the processor is a laptop computer.
16. An apparatus for use with a needle electrode and a return electrode for stimulating nerves within tissue, comprising:
means for sensing an electrical characteristic of a circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue;
means for applying an electrical pulse to the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue; and
means for adjusting an electrical parameter so as to produce a desired waveform in the circuit formed between the needle electrode and return electrode.
17. The apparatus of claim 16, wherein the means for adjusting the electrical parameter comprises:
means for receiving the sensed electrical characteristic and generating a control signal for adjusting the electrical parameter; and
means for receiving the control signal and conditioning the electrical pulse in response to the control signal.
18. The apparatus of claim 16, further comprising:
means for generating a background waveform signal in the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue; and
means for selecting whether the background waveform signal or the electrical pulse is applied to the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue.
19. The apparatus of claim 16, further comprising a means for displaying information regarding the sensed electrical characteristic of the circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue.
20. An apparatus for use with a needle electrode and a return electrode for stimulating nerves within tissue, comprising means for maintaining a desired waveform of an electrical pulse through a circuit formed when the needle electrode and return electrode are connected to the apparatus and applied to tissue as effective electrical characteristics between the needle electrode and return electrode change.
US11/381,741 2004-05-25 2006-05-04 Nerve Stimulator and Method Abandoned US20060195158A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/381,741 US20060195158A1 (en) 2004-05-25 2006-05-04 Nerve Stimulator and Method

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/853,590 US7212865B2 (en) 2004-05-25 2004-05-25 Nerve stimulator and method
US11/381,741 US20060195158A1 (en) 2004-05-25 2006-05-04 Nerve Stimulator and Method

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/853,590 Continuation US7212865B2 (en) 2004-05-25 2004-05-25 Nerve stimulator and method

Publications (1)

Publication Number Publication Date
US20060195158A1 true US20060195158A1 (en) 2006-08-31

Family

ID=35426417

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/853,590 Expired - Fee Related US7212865B2 (en) 2004-05-25 2004-05-25 Nerve stimulator and method
US11/381,741 Abandoned US20060195158A1 (en) 2004-05-25 2006-05-04 Nerve Stimulator and Method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/853,590 Expired - Fee Related US7212865B2 (en) 2004-05-25 2004-05-25 Nerve stimulator and method

Country Status (2)

Country Link
US (2) US7212865B2 (en)
WO (1) WO2005115532A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070213705A1 (en) * 2006-03-08 2007-09-13 Schmid Peter M Insulated needle and system
US20120226333A1 (en) * 2009-09-14 2012-09-06 Medizinische Universitaet Wien Punctual stimulation device
US20120296389A1 (en) * 2011-05-19 2012-11-22 Neuros Medical, Inc. High-frequency electrical nerve block
US9295841B2 (en) 2011-05-19 2016-03-29 Meuros Medical, Inc. High-frequency electrical nerve block
US9616234B2 (en) 2002-05-03 2017-04-11 Trustees Of Boston University System and method for neuro-stimulation
US10758723B2 (en) 2011-05-19 2020-09-01 Neuros Medical, Inc. Nerve cuff electrode for neuromodulation in large human nerve trunks
US11116965B2 (en) 2017-12-13 2021-09-14 Neuros Medical, Inc. Nerve cuff deployment devices
US11213682B2 (en) 2018-04-09 2022-01-04 Neuros Medical, Inc. Apparatuses and methods for setting an electrical dose
US11413458B2 (en) 2011-05-19 2022-08-16 Neuros Medical, Inc. Nerve cuff electrode for neuromodulation in large human nerve trunks
US11878172B2 (en) 2020-02-11 2024-01-23 Neuros Medical, Inc. System and method for quantifying qualitative patient-reported data sets

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8417352B2 (en) * 2004-10-19 2013-04-09 Meagan Medical, Inc. System and method for stimulating sensory nerves
US8086322B2 (en) 2004-10-19 2011-12-27 Meagan Medical Inc. Method and means for electrical stimulation of cutaneous sensory receptors
US20070073354A1 (en) * 2005-09-26 2007-03-29 Knudson Mark B Neural blocking therapy
US8027718B2 (en) 2006-03-07 2011-09-27 Mayo Foundation For Medical Education And Research Regional anesthetic
US20090204173A1 (en) 2007-11-05 2009-08-13 Zi-Ping Fang Multi-Frequency Neural Treatments and Associated Systems and Methods
US20090157155A1 (en) * 2007-12-18 2009-06-18 Advanced Bionics Corporation Graphical display of environmental measurements for implantable therapies
CA2716956A1 (en) * 2008-02-27 2009-09-03 Avi Livnat Atrial defibrillation using an implantable defibrillation system
US20090234236A1 (en) * 2008-03-14 2009-09-17 General Electric Company Nerve blood flow modulation for imaging nerves
US7890182B2 (en) 2008-05-15 2011-02-15 Boston Scientific Neuromodulation Corporation Current steering for an implantable stimulator device involving fractionalized stimulation pulses
US8702677B2 (en) * 2008-10-31 2014-04-22 Warsaw Orthopedic, Inc. Device and method for directional delivery of a drug depot
US8255057B2 (en) 2009-01-29 2012-08-28 Nevro Corporation Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions
AU2010238752B2 (en) 2009-04-22 2014-05-29 Nevro Corporation Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
EP2243510B1 (en) 2009-04-22 2014-04-09 Nevro Corporation Sytems for selective high frequency spinal cord modulation for inhibiting pain with reduced side effects
US8715223B2 (en) * 2009-07-22 2014-05-06 Warsaw Orthopedic, Inc. Device and method for delivery of a drug depot near the nerve
US8498710B2 (en) 2009-07-28 2013-07-30 Nevro Corporation Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
WO2011146498A2 (en) * 2010-05-17 2011-11-24 Rafael Development Corporation, Ltd. Configurable pulse generator
US8649874B2 (en) 2010-11-30 2014-02-11 Nevro Corporation Extended pain relief via high frequency spinal cord modulation, and associated systems and methods
WO2013036880A1 (en) 2011-09-08 2013-03-14 Thacker James R Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods
US8676331B2 (en) 2012-04-02 2014-03-18 Nevro Corporation Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection
US9833614B1 (en) 2012-06-22 2017-12-05 Nevro Corp. Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods
US9962546B2 (en) 2013-02-21 2018-05-08 Meagan Medical, Inc. Cutaneous field stimulation with disposable and rechargeable components
US9895539B1 (en) 2013-06-10 2018-02-20 Nevro Corp. Methods and systems for disease treatment using electrical stimulation
US10149978B1 (en) 2013-11-07 2018-12-11 Nevro Corp. Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
ES2546651B1 (en) * 2014-03-24 2016-11-16 Ionclinics And Deionic, S.L. Device for the recovery of tendinopathies and fibrillar tears
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
US10080877B2 (en) 2014-07-25 2018-09-25 Warsaw Orthopedic, Inc. Drug delivery device and methods having a drug cartridge
US11318310B1 (en) 2015-10-26 2022-05-03 Nevro Corp. Neuromodulation for altering autonomic functions, and associated systems and methods
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
WO2017132174A1 (en) 2016-01-25 2017-08-03 Nevro Corp. Treatment of congestive heart failure with electrical stimulation, and associated systems and methods
US10799701B2 (en) 2016-03-30 2020-10-13 Nevro Corp. Systems and methods for identifying and treating patients with high-frequency electrical signals
US11446504B1 (en) 2016-05-27 2022-09-20 Nevro Corp. High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods
USD802756S1 (en) 2016-06-23 2017-11-14 Warsaw Orthopedic, Inc. Drug pellet cartridge
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
WO2020150647A1 (en) 2019-01-17 2020-07-23 Nevro Corp. Sensory threshold and/or adaptation for neurological therapy screening and/or parameter selection, and associated systems and methods
US11590352B2 (en) 2019-01-29 2023-02-28 Nevro Corp. Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4924880A (en) * 1988-11-16 1990-05-15 Sion Technology, Inc. Dental anesthesia apparatus
US5871481A (en) * 1997-04-11 1999-02-16 Vidamed, Inc. Tissue ablation apparatus and method
US6029090A (en) * 1997-01-27 2000-02-22 Herbst; Ewa Multi-functional electrical stimulation system
US6269270B1 (en) * 1998-10-26 2001-07-31 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator
US6493588B1 (en) * 1998-03-18 2002-12-10 Mmc/Gatx Partnership No. 1 Electro-nerve stimulator systems and methods

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299230A (en) 1979-05-09 1981-11-10 Olympus Optical Co., Ltd. Stabbing apparatus for diagnosis of living body
CA1215128A (en) * 1982-12-08 1986-12-09 Pedro Molina-Negro Electric nerve stimulator device
US4515168A (en) 1983-07-22 1985-05-07 Chester Martin H Clamp-on nerve stimulator and locator
US5389069A (en) 1988-01-21 1995-02-14 Massachusetts Institute Of Technology Method and apparatus for in vivo electroporation of remote cells and tissue
US5368014A (en) * 1990-11-21 1994-11-29 Effner Biomet Gmbh Modular endoscope having easily replaceable parts
US5320109A (en) 1991-10-25 1994-06-14 Aspect Medical Systems, Inc. Cerebral biopotential analysis system and method
US5358514A (en) 1991-12-18 1994-10-25 Alfred E. Mann Foundation For Scientific Research Implantable microdevice with self-attaching electrodes
DK48092D0 (en) 1992-04-10 1992-04-10 Novo Nordisk As APPARATUS
US5305746A (en) 1992-09-29 1994-04-26 Aspect Medical Systems, Inc. Disposable, pre-gelled, self-prepping electrode
US5368041A (en) 1992-10-15 1994-11-29 Aspect Medical Systems, Inc. Monitor and method for acquiring and processing electrical signals relating to bodily functions
US5306236A (en) 1993-02-18 1994-04-26 Vickers Plc Needle electrode for use with hypodermic syringe attachment
US5993434A (en) 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
US5725514A (en) 1994-08-15 1998-03-10 A.V.I. - Advanced Visual Instruments, Inc. Adjustable miniature panoramic illumination and infusion system for retinal surgery
CA2229391C (en) 1995-04-10 2005-09-27 Admir Hadzic Peripheral nerve stimulation device for unassisted nerve blockade
US5853373A (en) 1996-08-05 1998-12-29 Becton, Dickinson And Company Bi-level charge pulse apparatus to facilitate nerve location during peripheral nerve block procedures
US6032064A (en) 1996-10-11 2000-02-29 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US6394953B1 (en) 2000-02-25 2002-05-28 Aspect Medical Systems, Inc. Electrode array system for measuring electrophysiological signals
US6009347A (en) 1998-01-27 1999-12-28 Genetronics, Inc. Electroporation apparatus with connective electrode template
US6032072A (en) 1998-01-30 2000-02-29 Aspect Medical Systems, Inc. Method for enhancing and separating biopotential signals
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6434410B1 (en) 1998-06-19 2002-08-13 Aspect Medical Systems, Inc. Electrode for measuring electrophysiological signals using liquid electrolytic gel with a high salt concentration
US6298256B1 (en) 1999-09-10 2001-10-02 Frank-Egbert Meyer Device and method for the location and catheterization of the surroundings of a nerve
US6599281B1 (en) 2000-05-03 2003-07-29 Aspect Medical Systems, Inc. System and method for adaptive drug delivery
EP1404214A2 (en) 2000-11-24 2004-04-07 CKM Diagnostics, Inc. Nerve stimulator output control needle with depth determination capability and method of use
CA2450945C (en) 2001-06-21 2008-09-16 Aspect Medical Systems, Inc. System and method for the detection and removal of radio frequency noise artifact from biopotential signals
CA2452367C (en) 2001-07-06 2008-10-28 Aspect Medical Systems, Inc. System and method for measuring bioelectric impedance in the presence of interference
EP2308553B1 (en) * 2001-10-18 2014-01-29 Uroplasty, Inc. Electro-nerve stimulator system
ATE417547T1 (en) 2002-01-04 2009-01-15 Aspect Medical Systems Inc ARRANGEMENT AND METHOD FOR CLASSIFICATION OF MENTAL DISORDERS USING EEG
CA2479916C (en) 2002-04-01 2013-10-29 Aspect Medical Systems, Inc. System and method of assessment of arousal, pain and stress during anesthesia and sedation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4924880A (en) * 1988-11-16 1990-05-15 Sion Technology, Inc. Dental anesthesia apparatus
US6029090A (en) * 1997-01-27 2000-02-22 Herbst; Ewa Multi-functional electrical stimulation system
US5871481A (en) * 1997-04-11 1999-02-16 Vidamed, Inc. Tissue ablation apparatus and method
US6493588B1 (en) * 1998-03-18 2002-12-10 Mmc/Gatx Partnership No. 1 Electro-nerve stimulator systems and methods
US6269270B1 (en) * 1998-10-26 2001-07-31 Birinder Bob Boveja Apparatus and method for adjunct (add-on) therapy of Dementia and Alzheimer's disease utilizing an implantable lead and external stimulator

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9616234B2 (en) 2002-05-03 2017-04-11 Trustees Of Boston University System and method for neuro-stimulation
US20070213705A1 (en) * 2006-03-08 2007-09-13 Schmid Peter M Insulated needle and system
US8942814B2 (en) * 2009-09-14 2015-01-27 Dr. Jozsef Constantin Szeles Punctual stimulation device
US20120226333A1 (en) * 2009-09-14 2012-09-06 Medizinische Universitaet Wien Punctual stimulation device
US9295841B2 (en) 2011-05-19 2016-03-29 Meuros Medical, Inc. High-frequency electrical nerve block
US8983612B2 (en) 2011-05-19 2015-03-17 Neuros Medical, Inc. High-frequency electrical nerve block
US8731676B2 (en) * 2011-05-19 2014-05-20 Neuros Medical, Inc. High-frequency electrical nerve block
US20120296389A1 (en) * 2011-05-19 2012-11-22 Neuros Medical, Inc. High-frequency electrical nerve block
US10758723B2 (en) 2011-05-19 2020-09-01 Neuros Medical, Inc. Nerve cuff electrode for neuromodulation in large human nerve trunks
US11413458B2 (en) 2011-05-19 2022-08-16 Neuros Medical, Inc. Nerve cuff electrode for neuromodulation in large human nerve trunks
US11116965B2 (en) 2017-12-13 2021-09-14 Neuros Medical, Inc. Nerve cuff deployment devices
US11752331B2 (en) 2017-12-13 2023-09-12 Neuros Medical, Inc. Nerve cuff deployment devices
US11213682B2 (en) 2018-04-09 2022-01-04 Neuros Medical, Inc. Apparatuses and methods for setting an electrical dose
US11730963B2 (en) 2018-04-09 2023-08-22 Neuros Medical, Inc. Apparatuses and methods for setting an electrical dose
US11878172B2 (en) 2020-02-11 2024-01-23 Neuros Medical, Inc. System and method for quantifying qualitative patient-reported data sets

Also Published As

Publication number Publication date
WO2005115532A3 (en) 2006-10-26
US20050267545A1 (en) 2005-12-01
WO2005115532A2 (en) 2005-12-08
US7212865B2 (en) 2007-05-01

Similar Documents

Publication Publication Date Title
US7212865B2 (en) Nerve stimulator and method
US8818503B2 (en) Method and apparatus for diagnosing and treating neural dysfunction
US6706016B2 (en) Nerve stimulator output control needle with depth determination capability and method of use
US8014876B2 (en) Treatment apparatus for applying electrical impulses to the body of a patient
US4541432A (en) Electric nerve stimulator device
US7706885B2 (en) Transcutaneous electrical nerve stimulation and method of using same
US8521262B2 (en) Methods and apparatus for localization, diagnosis, contact or activity detection of bio-electric tissue
AU2002243217A1 (en) Nerve stimulator output control needle with depth determination capability and method of use
JP2011182954A (en) Dysuria treatment device
KR20190088726A (en) Low-frequency micro current treatment apparatus measuring skin resistance value and control method thereof
RU2355443C1 (en) Method of scanner-therapy
WO2011106225A2 (en) Apparatus and method for treatment of pain with body impedance analyzer
US20070043405A1 (en) Method and apparatus for diagnosing and treating neural dysfunction
Visan et al. Peripheral nerve stimulators technology
Blad et al. Measurement of contact impedance of electrodes used for deep brain stimulation
Storper et al. The galvanically‐induced vestibulo‐ocular reflex in the cat

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION